Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia
X Peng,1 P Sun,2 D Novick,1 J Andrews,1 S Sun2 1Eli Lilly and Company, Indianapolis, IN, USA; 2Kailo Research Group, Indianapolis, IN, USA Objectives: To compare health care utilization of duloxetine initiators and pregabalin initiators among fibromyalgia patients in a real-world setting. Methods:...
Main Authors: | Peng X, Sun P, Novick D, Andrews J, Sun S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-01-01
|
Series: | Journal of Pain Research |
Online Access: | http://www.dovepress.com/real-world-comparison-of-health-care-utilization-between-duloxetine-an-a15460 |
Similar Items
-
Comparing common reasons for inpatient and outpatient visits between commercially-insured duloxetine or pregabalin initiators with fibromyalgia
by: Zhao Y, et al.
Published: (2012-10-01) -
Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
by: Ellis JJ, et al.
Published: (2014-10-01) -
Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care
by: Andrews JS, et al.
Published: (2013-11-01) -
Predictors of duloxetine adherence and persistence in patients with fibromyalgia
by: Cui Z, et al.
Published: (2012-06-01) -
Duloxetine for the management of fibromyalgia syndrome
by: Beth A Scholz, et al.
Published: (2009-07-01)